Fulgent Genetics FLGT
NASDAQ FLGT
$21.69 -0.16 (-0.73%)
At close: Sep 18, 2026 · 4:00 PM EDT

Fulgent Genetics (FLGT) Restructuring Costs (2022 - 2026)

Fulgent Genetics' (FLGT) quarterly Restructuring Costs came in at $300000.0 in Q2 2026, down 88.46% quarter-over-quarter from $2.6 million in Q1 2026.

Analysis

Fulgent Genetics (FLGT) Restructuring Costs (2022 - 2026) Analysis & Trends

Fulgent Genetics has disclosed Restructuring Costs across 3 years of filings, most recently posting $300000.0 for Q2 2026.

  • In Q2 2026, Restructuring Costs changed N/A year-over-year to $300000.0; the TTM figure through Jun 2026 stood at $6.5 million (up 8127.85% YoY), while the FY2025 annual figure was $1.5 million, changed N/A from the prior year.
  • Restructuring Costs came in at $300000.0 for Q2 2026 at Fulgent Genetics, down from $2.6 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $2.9 million in Q2 2022 to a low of -$26000.0 in Q4 2022.
  • Average Restructuring Costs over 3 years is $1.4 million, with a median of $1.5 million recorded in 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 Fulgent Genetics 596.80 Mn 334.14 Mn 25.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300,000.00
Mar 31, 2026 2.60 Mn
Dec 31, 2025 1.50 Mn
Sep 30, 2025 2.10 Mn
Dec 31, 2022 -26,000.00
Sep 30, 2022 105,000.00
Jun 30, 2022 2.90 Mn